Pa. study finds surgery risk with Ozempic, other popular weight-loss, diabetes drugs - PennLive
pennlive.comSubmitted by pennlive8281 in health
A four-year study out of Geisinger Medical Center found potential additional adverse effects for patients using the popular weight-loss, diabetes class of drugs known as GLP-1s. This time the effect concerns risks when having a common gastroenterology procedu…